Test Price
2,800 AED✅ Home Collection Available
DYNC1H1 Gene Intellectual Disability, Autosomal Dominant Type 13 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين DYNC1H1 للإعاقة الذهنية النوع 13 السائد جسديًا في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Clinical Excellence Delivered to Your Doorstep
-
✓
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Next-Generation Sequencing (Cert: INT/EGQ/2509DA/3139). All variants interpreted against 2026 ACMG/ClinGen guidelines.
-
✓
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain sample transport. VIP Mobile Phlebotomy available 8 AM – 11 PM daily, including weekends.
-
✓
Clinical Guidance: Complimentary telephonic post‑test result interpretation session with a DHA‑licensed genetic counsellor to contextualise findings within your family history.
-
✓
Insurance Verification: Direct billing assistance – send your insurance card via WhatsApp to +971 54 548 8731 for instant eligibility check.
Test Overview & Clinical Utility
This single‑gene sequencing analysis interrogates the entire coding region of DYNC1H1 using Next‑Generation Sequencing (NGS) to detect pathogenic variants associated with Autosomal Dominant Intellectual Disability Type 13 (MRD13). Early molecular confirmation enables precise reproductive counselling and individualised developmental support.
يُوفر هذا التحليل الجيني تشخيصًا دقيقًا للإعاقة الذهنية النوع 13 ويدعم الاستشارة الوراثية وتخطيط الرعاية المبكرة.
| Feature | Our Test – UAE | Standard Overseas Lab |
|---|---|---|
| Sequencing Depth | ≥100x with full exon coverage, verified by Sanger for any low‑confidence variant | Often 20–30x; variants may not be reflex‑confirmed |
| Turnaround Time | 3–4 weeks from sample receipt, with online status tracking | 4–8 weeks; no patient portal |
| Variant Interpretation | 2026 ACMG/ClinGen standards, reviewed by board‑certified clinical geneticist | Often automated pipeline; no clinical context integration |
| Post‑Test Support | Free 20‑min genetic counsellor consultation + Arabic‑speaking advisors | No included support; additional cost for counselling |
Physician Insight & Safety Protocol
“A genetic result is never a sentence – it is a compass. I encourage every family to interpret this report in the context of a comprehensive developmental paediatric evaluation and genetic counselling, because clinical correlation remains the cornerstone of sound medical decision‑making.”
— Dr. Prabhakar Reddy, DHA License: 61713011, Consultant Paediatrician & Clinical Geneticist
⛔ Medication and Safety Warning
Do not discontinue any prescribed medication, including anticonvulsants or neurodevelopmental therapies, based solely on this genetic result without consulting your treating physician.
Exclusion Criteria & Emergency Red Flags
- This test is not intended for asymptomatic minors in the absence of a court‑issued genetic testing order, in strict compliance with UAE Child Protection Law (CDS Law 2026).
- Individuals without a documented clinical suspicion of intellectual disability or a confirmed family history of DYNC1H1‑related disorders should not undergo this test.
- Emergency red flag: If you or your child experiences acute psychological distress, suicidal ideation, or sudden behavioural deterioration after receiving results, seek immediate help at the nearest Emergency Department or call 998 for ambulance services.
Frequently Asked Questions & Clinical Guidance
1. What does the DYNC1H1 gene test detect and how accurate is it?
This NGS test detects single nucleotide variants, small insertions/deletions, and copy number changes within the DYNC1H1 gene with 99.9% analytic sensitivity, enabling precise molecular diagnosis of autosomal dominant intellectual disability type 13.
All pathogenic and likely pathogenic variants are reported according to 2026 ACMG/AMP criteria. Benign variants are not disclosed. A negative result does not rule out other genetic disorders, so follow‑up clinical evaluation remains essential.
يكتشف تحليل DYNC1H1 الطفرات الجينية المسببة للإعاقة الذهنية النوع 13 بدقة تحليلية تصل إلى 99.9%، مما يسمح بتشخيص جزيئي دقيق.
2. How is the sample collected and what is the turnaround time?
A single venipuncture blood sample (3 mL in EDTA tube) or a dried blood spot on an FTA card is collected at your home by a DHA‑licensed phlebotomist within 24 hours of booking, with results delivered in 3 to 4 weeks.
You will receive a secure online report and a telephonic consultation slot automatically scheduled. FTA card collection is ideal for neonates and patients with difficult venous access.
تُسحب العينة في منزلك بواسطة ممرض مرخص خلال 24 ساعة من الحجز، و تُصدر النتائج خلال 3 إلى 4 أسابيع مع جلسة استشارة هاتفية.
3. Is this test covered by insurance or is there an age restriction?
We verify insurance coverage before the test via WhatsApp at +971 54 548 8731; the test is authorised for minors only when prescribed by a DHA‑licensed paediatrician or clinical geneticist, in line with UAE CDS Law 2026.
Adults with personal suspicion or family history may self‑refer, but a pre‑test genetic counselling session is mandatory to review implications. All personal data is protected under UAE PDPL and Federal Decree-Law No. 41 of 2024 (Art. 87).
يُتحقق من تغطية التأمين قبل الفحص، ولا يُجرى التحليل للقاصرين إلا بوصفة طبية من طبيب مرخص، تماشيًا مع قانون سلامة الطفل الإماراتي لعام 2026.
Medical Entity: This is performed by a DHA‑licensed diagnostic laboratory holding ISO 9001:2015 certification (INT/EGQ/2509DA/3139).
Data Privacy: All genetic data and personal health information are handled in strict accordance with UAE Federal Decree-Law No. 41 of 2024 on the Protection of Personal Data and Health Data and the UAE PDPL. Genetic data of minors is processed only with judicial consent per CDS Law 2026.
ICD‑10‑CM 2026 Codes: F79 (Intellectual disability, unspecified), Z13.79 (Encounter for screening for other genetic/chromosomal anomalies), Z14.8 (Genetic susceptibility to other disease). LOINC: 82939-5 (DYNC1H1 gene mutation detection).
Specialist Clinical Intent: Paediatricians (comprehensive neurodevelopmental assessment), Clinical Geneticists (variant interpretation & counselling), Neonatologists (early dysmorphology evaluation).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians